Celsion to Hold Annual Meeting: Shareholders May Participate by Telephone or Webcast

May 16, 2005
Celsion to Hold Annual Meeting: Shareholders May Participate by Telephone or WebcastCOLUMBIA, Md., May 16, 2005 (BUSINESS WIRE) -- CELSION CORPORATION (AMEX:CLN) will hold its annual meeting on Thursday, May 19, 2005 at 10:00 a.m. ET, at the Four Points Sheraton at the BWI Airport in Baltimore, Maryland, with simultaneous webcast and telephone access. The webcast is also being distributed over CCBN's Investor Distribution Network to both institutional and individual investors. Individual investors can listen to the webcast through CCBN's individual investor center at www.fulldisclosure.com or by visiting any of the investor sites in CCBN's Individual Investor Network. Institutional investors can access the call via CCBN's password protected event management site, StreetEvents (www.streetevents.com). The webcast can also be accessed at Celsion Corporation's website at www.celsion.com. The replay of the webcast will be available for 90 days. The archived webcast can be accessed in the same manner as the live webcast of the meeting.

To participate in the meeting by telephone, interested parties should dial 800-599-9816 (domestic) and 617-847-8705 (international), (access code: 44525147) to register ten minutes before the meeting is scheduled to begin.

The audio will be archived for replay from Friday, May 19, 2005 at 12:00 p.m. through 11:59 p.m. on Friday, August 19, 2005. The replay can be accessed at 888-286-8010 (domestic) and 617-801-6888 (international), (access code: 87051427). The audio will also be available on the Company's web site, http://www.celsion.com/

Celsion has research, license or commercialization agreements with leading institutions such as the National Institutes of Health, Duke University Medical Center, Massachusetts Institute of Technology, Harbor UCLA Medical Center, Montefiore Medical Center and Memorial Sloan-Kettering Cancer Center in New York City, Roswell Park Cancer Institute in Buffalo, New York, and Duke University. For more information on Celsion, visit our website: http://www.celsion.com.

Celsion wishes to inform readers that forward-looking statements in this release are made pursuant to the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995. Readers are cautioned that such forward-looking statements involve risks and uncertainties including, without limitation, unforeseen changes in the course of research and development activities and in clinical trials by others; possible acquisitions of other technologies, assets or businesses; possible actions by customers, suppliers, competitors, regulatory authorities; and other risks detailed from time to time in the Company's periodic reports filed with the Securities and Exchange Commission.

SOURCE: Celsion Corporation 

Celsion Corporation
Tony Deasey, 410-290-5390
tony@celsion.com
  or
General Info:  
Financial Relations Board
Marilynn Meek, 212-827-3773
mmeek@financialrelationsboard.com
  or
Investor Info: 
Susan Garland, 212-827-3775
sgarland@financialrelationsboard.com